Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of MBX Biosciences Inc (NASDAQ: MBX) was $22.55 for the day, up 9.36% from the previous closing price of $20.62. In other words, the price has increased by $9.36 from its previous closing price. On the day, 0.65 million shares were traded. MBX stock price reached its highest trading level at $22.7 during the session, while it also had its lowest trading level at $20.34.
Ratios:
Our analysis of MBX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 19.50 and its Current Ratio is at 19.50. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On October 15, 2025, Truist started tracking the stock assigning a Buy rating and target price of $50.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Oct 20 ’25 when Hawryluk P. Kent bought 20,000 shares for $13.64 per share. The transaction valued at 272,790 led to the insider holds 468,277 shares of the business.
Hoerter Steven L. bought 20,000 shares of MBX for $264,984 on Oct 17 ’25. The Director now owns 20,000 shares after completing the transaction at $13.25 per share. On Sep 26 ’25, another insider, Heron Patrick J, who serves as the Director of the company, bought 666,666 shares for $18.00 each. As a result, the insider paid 11,999,988 and bolstered with 5,219,440 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MBX now has a Market Capitalization of 1008334400 and an Enterprise Value of 533285664.
Stock Price History:
The Beta on a monthly basis for MBX is 1.28, which has changed by -0.11197245 over the last 52 weeks, in comparison to a change of 0.13367426 over the same period for the S&P500. Over the past 52 weeks, MBX has reached a high of $27.50, while it has fallen to a 52-week low of $4.81. The 50-Day Moving Average of the stock is 46.56%, while the 200-Day Moving Average is calculated to be 88.10%.
Shares Statistics:
MBX traded an average of 1.25M shares per day over the past three months and 990640 shares per day over the past ten days. A total of 33.59M shares are outstanding, with a floating share count of 26.51M. Insiders hold about 40.71% of the company’s shares, while institutions hold 48.74% stake in the company. Shares short for MBX as of 1760486400 were 3909541 with a Short Ratio of 3.12, compared to 1757894400 on 4226517. Therefore, it implies a Short% of Shares Outstanding of 3909541 and a Short% of Float of 14.01.
Earnings Estimates
. The current market rating for MBX Biosciences Inc (MBX) reflects the collective analysis of 5.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.66, with high estimates of -$0.54 and low estimates of -$0.82.
Analysts are recommending an EPS of between -$2.31 and -$2.9 for the fiscal current year, implying an average EPS of -$2.6. EPS for the following year is -$2.51, with 6.0 analysts recommending between -$2.21 and -$2.78.
